Daniel Janney insider trades: Krystal Biotech (KRYS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Daniel reports to the SEC
and 20 more companies
Open-market buys and sales
50 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | KRYS | ↓ Sell | 11,803 | $275.59 | $3.3M | Directly beneficially owned by Alta Bioe | Mar 3, 2026 (4d) |
| Feb 26, 2026 | KRYS | ↓ Sell | 22,266 | $271.09 | $6.0M | Directly beneficially owned by Alta Bioe | Feb 26, 2026 (0d) |
| Feb 24, 2026 | KRYS | ↓ Sell | 37,895 | $266.88 | $10.1M | Direct | Feb 26, 2026 (2d) |
| Jun 9, 2023 | KRYS | ↓ Sell | 50,000 | $128.36 | $6.4M | Directly beneficially owned by Alta Bioe | Jun 9, 2023 (0d) |
| May 19, 2023 | KRYS | ↓ Sell | 50,000 | $95.02 | $4.8M | Directly beneficially owned by Alta Bioe | May 23, 2023 (4d) |
| May 9, 2023 | KRYS | ↓ Sell | 17,100 | $90.74 | $1.6M | Directly beneficially owned by Alta Bioe | May 11, 2023 (2d) |
| Apr 19, 2023 | KRYS | ↓ Sell | 7,900 | $90.32 | $713K | Directly beneficially owned by Alta Bioe | Apr 21, 2023 (2d) |
| Sep 21, 2022 | ALLK | ↑ Buy | 475,000 | $5.02 | $2.4M | By Alta Partners NextGen Fund I, L.P. | Sep 23, 2022 (2d) |
| Dec 10, 2021 | KRYS | ↓ Sell | 100,000 | $70.50 | $7.0M | By Alta Bioequities L.P | Dec 14, 2021 (4d) |
| Sep 17, 2021 | TYRA | ↑ Buy | 156,250 | $16.00 | $2.5M | Indirect | Sep 17, 2021 (0d) |
| Mar 26, 2021 | ALLK | ↓ Sell | 17,308 | $115.17 | $2.0M | By Alta Bioequities L.P. | Mar 30, 2021 (4d) |
| Mar 22, 2021 | ALLK | ↓ Sell | 13,148 | $119.70 | $1.6M | By Alta Bioequities L.P. | Mar 24, 2021 (2d) |
| Mar 15, 2021 | ALLK | ↓ Sell | 10,779 | $124.42 | $1.3M | By Alta Bioequities L.P. | Mar 16, 2021 (1d) |
| Mar 11, 2021 | ALLK | ↓ Sell | 6,106 | $124.63 | $761K | By Alta Bioequities L.P. | Mar 11, 2021 (0d) |
| Aug 30, 2019 | KRYS | ↓ Sell | 88,684 | $46.46 | $4.1M | Indirect | Sep 3, 2019 (4d) |
| Jul 23, 2018 | ALLK | ↑ Buy | 250,000 | $18.00 | $4.5M | Indirect | Jul 23, 2018 (0d) |
| Sep 22, 2017 | KRYS | ↑ Buy | 200,000 | $10.00 | $2.0M | Indirect | Sep 25, 2017 (3d) |
| Mar 21, 2017 | ESPR | ↓ Sell | 350,000 | $45.80 | $16.0M | Indirect | Mar 23, 2017 (2d) |
| Mar 17, 2017 | VIVE | ↑ Buy | 500,000 | $4.00 | $2.0M | Indirect | Mar 21, 2017 (4d) |
| Jun 17, 2016 | VIVMF | ↑ Buy | 200,000 | $5.00 | $1.0M | Indirect | Jun 20, 2016 (3d) |
| Dec 30, 2015 | NEOT | ↓ Sell | 797,987 | $1.51 | $1.2M | Direct | Dec 30, 2015 (0d) |
| Dec 15, 2015 | NEOT | ↓ Sell | 529,261 | $1.44 | $762K | Direct | Dec 17, 2015 (2d) |
| Nov 24, 2015 | VIVMF | ↑ Buy | 857,142 | $0.70 | $600K | Indirect | Nov 25, 2015 (1d) |
| Jun 8, 2015 | ZSPH | ↓ Sell | 175,427 | $57.86 | $10.1M | Direct | Jun 9, 2015 (1d) |
| Jun 4, 2015 | ZSPH | ↓ Sell | 111,597 | $57.30 | $6.4M | Direct | Jun 5, 2015 (1d) |
| Jun 2, 2015 | ZSPH | ↓ Sell | 296,423 | $58.00 | $17.2M | Direct | Jun 2, 2015 (0d) |
| May 12, 2015 | VIVMF | ↑ Buy | 2,702,702 | $0.37 | $1000K | Indirect | May 14, 2015 (2d) |
| Apr 14, 2015 | CBYL | ↑ Buy | 877,500 | $5.00 | $4.4M | Indirect | Apr 14, 2015 (0d) |
| Dec 10, 2014 | TRVN | ↑ Buy | 500,000 | $4.00 | $2.0M | Indirect | Dec 10, 2014 (0d) |
| Nov 25, 2014 | NEOT | ↓ Sell | 149,286 | $14.00 | $2.1M | Alta Partners VIII, LP | Nov 25, 2014 (0d) |
| Nov 25, 2014 | NEOT | ↑ Buy | 70,000 | $14.00 | $980K | Alta Partners VIII, LP | Nov 25, 2014 (0d) |
| Oct 21, 2014 | ESPR | ↑ Buy | 500,000 | $20.00 | $10.0M | Indirect | Oct 21, 2014 (0d) |
| Sep 23, 2014 | PLCSD | ↑ Buy | 1,895,788 | $0.53 | $1.0M | Indirect | Sep 25, 2014 (2d) |
| Jul 29, 2014 | IMDZ | ↑ Buy | 299,559 | $12.00 | $3.6M | Direct | Jul 31, 2014 (2d) |
| Jun 23, 2014 | ZSPH | ↑ Buy | 200,000 | $18.00 | $3.6M | Direct | Jun 25, 2014 (2d) |
| May 22, 2014 | AERI | ↓ Sell | 300,000 | $16.00 | $4.8M | Direct | May 27, 2014 (5d) |
| Apr 1, 2014 | AGTC | ↑ Buy | 155,645 | $12.00 | $1.9M | Indirect | Apr 1, 2014 (0d) |
| Feb 5, 2014 | TRVN | ↑ Buy | 472,410 | $7.00 | $3.3M | Indirect | Feb 7, 2014 (2d) |
| Oct 30, 2013 | AERI | ↑ Buy | 110,000 | $10.00 | $1.1M | Direct | Nov 1, 2013 (2d) |
| Jul 1, 2013 | ESPR | ↑ Buy | 235,714 | $14.00 | $3.3M | By Alta Partners VIII, L.P. | Jul 1, 2013 (0d) |
| Apr 20, 2011 | ELLI | ↓ Sell | 322,998 | $6.00 | $1.9M | Direct | Apr 21, 2011 (1d) |
| Apr 20, 2011 | ELLI | ↓ Sell | 4,079 | $6.00 | $24K | Indirect | Apr 21, 2011 (1d) |
| Feb 16, 2011 | ACRX | ↑ Buy | 680,000 | $5.00 | $3.4M | Direct | Feb 18, 2011 (2d) |
| Jan 6, 2010 | ANSV | ↓ Sell | 372,999 | $0.09 | $34K | By AP VIII, LP | Jan 8, 2010 (2d) |
| Jan 6, 2010 | ANSV | ↓ Sell | 30,612 | $0.09 | $3K | By ACP III, LP | Jan 8, 2010 (2d) |
| Jan 6, 2010 | ANSV | ↓ Sell | 1,039 | $0.09 | $95 | By AEP III, LLC | Jan 8, 2010 (2d) |
| Sep 8, 2009 | TPTX | ↓ Sell | 717,837 | $0.22 | $161K | Indirect | Sep 8, 2009 (0d) |
| Nov 14, 2006 | DVAX | ↓ Sell | 4,970 | $6.05 | $30K | Direct | Nov 14, 2006 (0d) |
| Oct 14, 2005 | CTRX | ↓ Sell | 166,937 | $13.00 | $2.2M | Indirect | Oct 18, 2005 (4d) |
| Oct 12, 2005 | CTRX | ↓ Sell | 247,314 | $13.00 | $3.2M | Indirect | Oct 14, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KRYS insiders
Open-market trades in the last 12 months
About Daniel Janney's insider trades
Daniel Janney is a director at Krystal Biotech (KRYS). Since Oct 12, 2005, Daniel has reported 20 open-market purchases worth $54.5M and 30 sales worth $115.9M on SEC Form 4. In the last 12 months: 3 sales ($19.4M).
Their filings also include grants and awards (49 filings), conversions (18 filings), other transactions (9 filings), option exercises (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KRYS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.